Enhanced Risk Management in Decentralized Clinical Trials I’ve been [...]
Dr. Robert Berube will be speaking at HIMSS Global Health Conference & Exhibition about the advantages of cloud-based digital patient engagement and e-Consent technology. In the presentation, Dr. Berube will highlight 5thPort's e-Consent capabilities and how it helped the clinic realize the value in the way of administrative efficiencies, the reduced risk of uninformed patients and the documented improvements in patient experiences.
Learn how 5thPort, a new Cloud-based digital patient engagement and e-Consent solution, is built to help contract research organizations (CROs) address four primary challenges in both site-based and decentralized clinical trials (DCTs).
Discover how 5thPort can help sites, sponsors, CROs, and solution providers save trial costs and mitigate risk with a new Cloud-based digital patient engagement and e-Consent solution.
5thPort™ to Exhibit at Future Trials Conference: Decentralized, Direct to Patient & Clinical Research
5thPort™ is excited to exhibit at the Future Trials Conference scheduled for June 22, 2021.
5thPort™ is excited to partner with the Court Square Group to help life science companies streamline clinical trials and improve outcomes.
Dr. Rob Berube of 5thPort™ to Participate in Panel Discussion at Michigan Health Information Network’s Virtual Conference
Dr. Rob Berube, co-founder of 5thPort™, will participate in a panel discussion facilitated by the Michigan Health Information Network (MiHIN).
5thPort™ is excited to exhibit at Clinical Trials Ontario (CTO) 2021's virtual conference, scheduled for March 23, 24, and 25, 2021.
The 8 Common Informed Consent Form Mistakes on IRB Audits [...]
Long Live Decentralized Trials Massive disruption from COVID-19 is [...]